other

Updated:

VistaLab Technologies

The adjustable ergonomic ovation pipettes offer Superior performance, ideal ergonomics and innovative features in one unique, patented design.

VistaLab Technologies

The adjustable ergonomic ovation pipettes offer Superior performance, ideal ergonomics and innovative features in one unique, patented design. We feature the world's only aliquoting pipet controller

General information

Firm type

other

Location

Region

North America

Country

United States

City

Palo Alto

Corporate office

Palo Alto, CA, United States

Additional offices

Burlingame, CA · Mountain View, CA · New York, NY · Chicago, IL · Seoul, South Korea · Hong Kong Island, Hong Kong

Sector focus

Life SciencesHealthcareIndustrial Tech

Frequently asked questions

Who owns VistaLab Technologies?

VistaLab Technologies is owned by CELLTREAT Scientific Products, which acquired the company in March 2022. CELLTREAT is a plastics manufacturer of cell culture and liquid handling consumables based in New York. The combined entity operates under the CELLTREAT umbrella.

Is VistaLab a family office or an investment firm?

No — VistaLab Technologies is an operating company that manufactures pipettes and lab consumables. It is not a family office, asset manager, or investment vehicle. Its structure is that of a portfolio company within the CELLTREAT Scientific Products group.

What products does VistaLab manufacture?

VistaLab produces the Ovation adjustable ergonomic pipette, the only aliquoting pipet controller on the market, and a line of reagent reservoirs. The company emphasizes ergonomic design, accuracy, and an unmatched lifetime warranty for its pipettes.

Where are VistaLab's offices located?

VistaLab has offices in Palo Alto, Burlingame, Mountain View, New York, and Chicago in the United States, plus Seoul, South Korea and Hong Kong Island, Hong Kong. Its headquarters is in Palo Alto, California.

Who are VistaLab's customers?

VistaLab sells to research and clinical laboratories that require precision liquid handling. This includes academic, pharmaceutical, biotechnology, and hospital labs worldwide.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Palo Alto other profiles